Johnson & Johnson Aandeel

121,70USD 2,18USD 1,82%
<
Fundamenteel
Balans
Taxaties
Dividend/AvA
>
<
Bedrijf
Kalender
Profiel
>
<
Gerelateerd
Obligaties
>

Taxaties voor Johnson & Johnson

2016 2017e 2018e 2019e 2020e
Dividend 3,15 3,34 3,55 3,77 3,86
Dividendrendement (in %) 2,71 2,91 3,09 3,28 3,36
K/W-verhouding 17,24 16,32 15,47 14,59 13,72
Winst/Aandeel 6,73 7,05 7,43 7,88 8,38
Meer nieuws

Analisten over Johnson & Johnson

13-6-2016 Johnson & Johnson Neutral Goldman Sachs Group Inc.
meer analisten

Johnson & Johnson Peer Group

Abbott Laboratories 45,40
0,9%
Alexion Pharmaceuticals 130,44
-0,3%
AstraZeneca 46,01
1,0%
Bayer 105,10
-2,6%
Beiersdorf 86,82
-0,1%
Celgene 119,46
0,2%
Fresenius Medical Care 78,67
-0,7%
Fresenius 76,62
-0,5%
GlaxoSmithKline 16,33
-1,3%
Johnson & Johnson 121,70
1,8%
Merck 62,00
-0,7%
Merck 102,75
-0,2%
MorphoSys 52,95
1,2%
Nestle SA 74,80
0,7%
Novartis 77,60
-0,3%
Pfizer 34,06
1,4%
Procter & Gamble 86,90
0,1%
Roche 248,20
-0,7%
STADA Arzneimittel 57,70
0,2%
Sanofi 80,13
-0,2%
Unilever 44,37
-0,1%
pagehit

Invoer toevoegen

Wat denkt u?

Profiel Johnson & Johnson

naar bedrijfsprofiel
Johnson & Johnson is an investment holding company with interests in health care products. It engages in research and development, manufacture and sale of personal care hygienic products, pharmaceuticals and surgical equipment. The company operates through the following business segments: Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes products used in the baby care, skin care, oral care, wound care and women's health care fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms. The baby care franchise includes the JOHNSON'S Baby line of products. The Pharmaceutical segment includes products in the anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis and vaccines. The Medical Devices segment includes products distributed to wholesalers, hospitals and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. These include products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. Johnson & Johnson was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

indices#seotext#content#us4781601046

Aandelenkoers Johnson & Johnson in USDPush activeren

Koers 121,70 USD 2,18 1,82 %
Tijd 22:15:07
Handelsdatum 23.02.2017
Opening 119,52
Slot 121,70
Hoogste 121,90
Laagste 119,49
52 W. Hoog 126,07
52 W. Laag 104,77
52 W. Perf.
Volume (Aantal) 2.419.726
Marktkap. (EUR) 309,08 Mrd
Beurs
De koers van 121,70 USD aan de beurs New York komt bij de actuele wisselkoers overeen USD/EUR met een koers van 114,98 Euro.

Naar aandeel Johnson & Johnson

ISIN US4781601046
Indices Dow Jones, S&P 500, BX Swiss - USA, S&P 100, NYSE US 100

Johnson & Johnson Kerncijfers

Marktkapitalisatie in Euro 309,08 Mrd
Vrij verhandelbaar in % 99,89
Aantal Aandelen 2.720,53
Kasstroom/Aandeel in lokale valuta 6,47
Boekwaarde/Aandeel in lokale valuta 27,40
60 Dagen Volatiliteit 14,61
K/B verhouding 4,24

Johnson & Johnson Historische koersen

22-2-2017 119,52 1.802.444
21-2-2017 119,66 2.368.536
17-2-2017 118,86 3.390.168
16-2-2017 118,08 2.664.112
15-2-2017 117,20 1.778.977

Aandelen in dezelfde sector met betere 1J Perf.

SIGA Technologies Inc. 591,6 %
Exelixis Inc. 538,0 %
Ariad Pharmaceuticals Inc. 382,2 %
Array BioPharma Inc. 352,3 %
EXACT Sciences Corp. 272,2 %